Oxford Technology Management
Venture capitalOxford · Pre-Seed–Series A · 5 people tracked
Also known as Grillcastle Limited · Seed Capital Limited
Investment thesis
Oxford Technology invests in startup and early-stage technology companies located in and around Oxford through SEIS and EIS tax-advantaged funds. Its flagship three-year fund allocates capital across roughly eight tech startups, deploying SEIS seed funding in year one and EIS follow-on funding to strong performers in later years; a separate knowledge-intensive EIS fund invests in five more mature portfolio companies. The team, describing itself as scientists focused on the underlying science, screens a large deal flow (selecting roughly 5 per 1,000 annually) and works closely with founders on business model and pricing. It typically provides up to £150k of SEIS seed funding and up to £300k of EIS follow-on capital.
Source: firm website, verified Aug 3, 2026.
Team · 5 people
from the firm's website & public directoriesWhat they invest in
from 31 of 44 portfolio companiesBiotech ×15Healthtech ×15Medical Devices ×14Deep Tech ×13AI & Machine Learning ×10Hardware ×8Cleantech ×3Digital Health ×3
HQs:United Kingdom×13
Who they back
founder profiles across 17 portfolio companiesFounding team size:solo founder×82 founders×63 founders×24+ founders×1
Investments · 44 tracked
founders shown can be your intro pathActive Needle Technology develops active (vibrating) needle technology to improve ultrasound-guided needle interventional procedures.
Deep TechHardwareHealthtechMedical Devices
Ian Quirk(Founder & CEO)Muhammad Sadiq(Founder & Senior Technical Officer)
Co-investorsOxford Investment Opportunity Network (OION)
Combat is a clinical-stage cancer treatment company focused on developing therapies for bladder and prostate cancer.
BiotechHealthtechMedical Devices
Edward Bruce-White(CEO/Co-Founder)Alberto Martinez Albalat(Director of R&D, Founder and Chairman)
Co-investorsNW Angel
Septest develops rapid point-of-need diagnostic tests for detecting infections and inflammation, including its multi-marker TRISEP test aimed at pre-hospital and community triage.
BiotechHealthtechMedical Devices
Oxford Cancer Analytics develops a diagnostics platform that combines reproducible proteomic measurement with AI to produce evidence-based insights supporting clinical decision-making.
AI & Machine LearningBiotechMedical DevicesOxford, GB
Andreas Halner(Founder and Head of Healthcare AI)inHeinrich Roder(Chief Technology Officer)inDaniel Szulc(Chief Product Officer)in
Co-investorsEka VenturesCross-Border Impact VenturesMeridian Health VenturesUK Innovation & Science Seed FundCivilization Ventures Management, LlcDigitalDx Ventures+1 more
Accelerated Diagnostics is developing decentralised diagnostics for human and veterinary markets, with a product launch planned for July 2026.
BiotechHealthtechMedical Devices
Beyond Fence provides ISO-compliant safety solutions for industrial robotics and automation, focused on keeping human operators safe and in control while improving efficiency.
Advanced ManufacturingHardwareRobotics
Bioarchitech develops oncolytic virus therapies and RNA-based immunotherapy candidates for cancer treatment.
AI & Machine LearningBiotechDeep TechHealthtech
Geoff Hale(Founder, Chairman)Lili Wang(Scientific Advisor & Co-founder)Hannah Chen(Scientific Advisor & Co-founder)
Covatic develops an on-device advertising platform powered by AI and machine learning that identifies user cohorts and delivers targeted ads while preserving consumer privacy.
AdTechAI & Machine LearningIoTLondon, GB
Nick Pinks(Founder)in
Co-investorsCreative UKTechstars
Curileum develops regenerative medicine therapies targeting intestinal stem cells to prevent colorectal cancer.
BiotechHealthtechMedical DevicesLondon, GB
Dr Jeff Moore(Founder & CEO)Jeff Moore(CEO & Founder)
Co-investorsAtlas VentureBiotechnology Value FundCanaan PartnersProspect Venture Partners
Co-investorsGreat Stuff Ventures
Etcembly builds EMLy Co-pilot, an AI platform with a conversational interface that unifies biologics design workflows—including structural modeling, variant generation, and molecule optimization—into a single tool.
AI & Machine LearningBiotechDeep Tech
Flarebright develops patented software and machine learning technologies that add capabilities such as autonomous flight and flight safety systems to robotic and crewed vehicles, including drones.
AI & Machine LearningDefense TechRoboticsUK, GB
Dr. Kelvin Hamilton(Founder & CEO)Dr. Conrad Rider(Co-founder & CTO)Dr. Carl Sequeira(Interim CTO)Gavin McEwan(Finance Director)
Co-investorsOxford Investment Opportunity Network (OION)
Hydregen develops biocatalysis platform technologies that integrate into existing chemical manufacturing infrastructure, aiming to cut process costs by 40-50% while lowering energy use and carbon emissions.
BiotechCleantechNew Materials
Co-investorsFuture Planet CapitalOxford Investment Opportunity Network (OION)UK Innovation & Science Seed Fund
Co-investorsConduit ConnectIW CapitalOxford Investment Opportunity Network (OION)XTX Markets
Mach42 develops AI tools for high-performance computing tasks, including analog circuit simulation and test plan development for semiconductors as well as real-time fusion control mechanisms.
AI & Machine LearningDeep TechSemiconductors
MetalloBio is an antimicrobials development company creating a new class of metal-based, broad-spectrum antibacterial agents to treat drug-resistant "superbug" infections.
BiotechDeep TechHealthtech
Kirsty Louise Smitten(Founder)
MitoRx is a preclinical-stage biotech developing MTRX31, a first-in-class small molecule that restores mitochondrial metabolism to eliminate ectopic fat in patients with metabolically unhealthy, high-risk obesity.
BiotechLongevity
Jon R.(Founder)in
Co-investorsFuture Planet CapitalOxford Investment Opportunity Network (OION)UK Innovation & Science Seed FundWren Capital
Neurolase develops AI-powered technology for brain surgery, aiming to improve surgical precision and patient outcomes in neurosurgery, particularly for brain tumor resection.
AI & Machine LearningDeep TechHealthtechMedical Devices
Monika Kott(Co-Founder & CEO)Babar Vaqas(Co-Founder & CMO)
Co-investorsZinc
Nikalyte manufactures physical vapor deposition (PVD) systems and instruments for thin-film and nanoparticle deposition serving research institutions, universities, and industrial customers.
AI & Machine LearningDeep TechHardwareNew Materials
Alistair Kean(Founder)Dave Mason(Founder)Srinivasa Rao Saranu(Founder)Mark Vaughan(Founder)
ONI develops the Nanoimager, an automated super-resolution imaging system.
BiotechDeep TechHardwareMedical DevicesOxford, GB
Co-investorsARCH Venture PartnersArtis VenturesFuture Planet CapitalVertical Venture PartnersCasdin Capital
Orbit Discovery provides peptide discovery solutions for pharmaceutical and biotechnology companies, serving both large pharmaceutical firms and smaller biotech enterprises.
AI & Machine LearningBiotechDeep TechHealthtechOxford, GB
Neil Butt(CEO)
Co-investorsFuture Planet CapitalOxford Science EnterprisesPerivoli Innovations
OVO Biomanufacturing offers a cloud-based software platform that helps viral vaccine manufacturers manage and reduce defective interfering particles (DIPs) to improve production yields.
Advanced ManufacturingBiotechSaaS
Sustainable laundry service disrupting the traditional cleaning industry.
Co-investorsConduit ConnectOxford Investment Opportunity Network (OION)Vala Capital
Process Vision develops optical measurement and imaging technology for the oil and gas industry, focused on improving process efficiency, reducing maintenance costs, and lowering emissions.
Deep TechEnergyIoTRobotics
Paul
Refeyn develops mass photometry instruments that measure the mass of individual biomolecules in solution without labels, enabling analysis of protein purity, interactions, and viral vector characterization for research and manufacturing applications.
BiotechDeep TechHardwareMedical DevicesOxford, GB
Philipp Kukura(Founder)Dan Cole(Chief Scientist and co-founder)Justin Benesch(Co-founder)
Co-investorsOxford Science EnterprisesHorizons Ventures
Sasets is a form management and data collection platform that enables organizations to create, deploy, and manage digital forms across mobile and desktop devices.
Cloud ComputingConstruction TechEnterprise SoftwareSaaS
Co-investorsBritish Design Fund
Surrey Hydrogen develops green hydrogen production technology.
CleantechClimate TechEnergyNew MaterialsDidcot, GB
Dr Bahman Amini Horri(Founder & Advisor)Dakota Johnston(CEO & Founder)
Co-investorsFuture Planet CapitalUK Innovation & Science Seed Fund
TTP develops the Thermo Trauma Port, a novel patient transfer device for the trauma care pathway, created with a consortium including East Anglian Air Ambulance, University Hospital of Birmingham and the University of Portsmouth.
HardwareHealthtechMedical Devices
Mary Anne Cordeiro(Founder & CEO)
Co-investorsAnglia Capital Group
Veirulence develops first-in-class non-antibiotic small molecule therapeutics that target bacterial virulence factors to treat resistant infections, with an initial focus on the WHO priority pathogen Pseudomonas aeruginosa.
BiotechDeep TechHealthtech
Zayndu manufactures and operates ActivatedAir™, a proprietary system for controlled environment agriculture that enhances seed treatment and plant growth.
AgTechCleantechDeep TechFoodTechHardware
Felipe Iza(Founder)
Portfolio news
latest coverage across their companiesCovatic · insidermedia.com · Jun 26, 2026
MitoRx Therapeutics · globenewswire.com · Jun 9, 2026
Principals & officers · per Companies House
what is this? ⓘDirector · British
Director · Italian · since 2012
John Lucius Arthur Cary — 25–50% of shares
Frequently asked questions
- How many investments has Oxford Technology Management made?
- Oxford Technology Management has 44 tracked investments.
- What stage does Oxford Technology Management invest at?
- Oxford Technology Management invests at the Pre-Seed, Seed, Series A stages.
- What is Oxford Technology Management's typical check size?
- Oxford Technology Management typically writes checks of $200K – $400K.
- What sectors does Oxford Technology Management focus on?
- Oxford Technology Management focuses on Advanced Manufacturing, AgTech, Biotech, Data & Infrastructure, Deep Tech, Enterprise Software, Hardware, Healthtech, IoT, Medical Devices, New Materials, Robotics, SaaS, Sector Agnostic, Semiconductors, Space Tech.
- Where is Oxford Technology Management located?
- Oxford Technology Management is headquartered in Oxford, GB.
- Does Oxford Technology Management lead rounds?
- Yes, Oxford Technology Management leads investment rounds.
- Who does Oxford Technology Management co-invest with?
- Oxford Technology Management most often shares deals with Oxford Investment Opportunity Network (OION), Future Planet Capital, UK Innovation & Science Seed Fund, among 24 tracked co-investors.
Media · Podcasts & interviews
featuring the teamMaster Investor Show 2024 – Lucius Cary and Andrea Mica – Oxford Technology Management Ltd
Master Investor · Lucius Cary
Master Investor Show 2023 – Lucius Cary and Andrea Mica – Oxford Technology Management Ltd
Master Investor · Lucius Cary
Images
Similar investors
Everywhere Ventures is an early-stage venture firm, backed by a community of founders and operators as LPs, that writes early checks (including pre-seed) into startups across many sectors and geographies.
Cowin Capital Group is a Chinese investment management firm with extensive experience investing in and exiting technology, healthcare, and industrial companies, many of which have gone public on Chinese and Hong Kong exchanges.
MPG Fund is an early-stage venture investor backing technology startups.
A globally recognized venture capital firm designed to provide access to highly competitive venture deals to individual investors, consistently recognized for top-decile DPI performance and as one of the most active US venture firms.
UntroD Capital is a deep-tech-focused investment firm that backs research-and-development-driven startups whose innovative technologies address challenges facing the planet and humanity, an approach it terms 'Real Tech'.